Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-17Clinical Trial Update: Study of Pathways Curriculum for Use With WPD [NA]
Completed the clinical trial evaluating the Pathways Curriculum for use with WPD in treating depression.
-
CLINICAL_TRIALS trial_result · 2012-10-17Clinical Trial Update: Group Therapy Program for Women With Physical Disabilities [NA]
A completed clinical trial from Oregon Health and Science University evaluated a group therapy program for women with physical disabilities …
-
CLINICAL_TRIALS research · 2012-10-15Clinical Trial Update: Effectiveness of Buddhist Monks in Providing Cognitive Behavior Therapy [NA]
This clinical trial investigates whether Buddhist monks delivering cognitive behavioral therapy can effectively treat Major Depressive Disor…
-
CLINICAL_TRIALS research · 2012-10-11Clinical Trial Update: COPE/Healthy Lifestyles for Teens: A School-Based RCT [NA]
ClinicalTrials.gov entry for a school-based randomized trial (COPE/Healthy Lifestyles for Teens) examining healthy lifestyle behaviors and d…
-
CLINICAL_TRIALS research · 2012-10-08Clinical Trial Update: Brain Imaging of Psychotherapy for Depression [NA]
A completed clinical trial from the University of North Carolina examined brain imaging during psychotherapy for major depressive disorder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-10-04Clinical Trial Update: Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer
A clinical trial investigating depression and interleukin-6 production in patients with ovarian epithelial cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-10-03Clinical Trial Update: Eszopiclone Co-Administered With Escitalopram for Insomnia in Elderly Adults With Major Depressive Disorder [Phase 4]
Phase 4 trial update evaluating safety and outcomes of co-administering eszopiclone with escitalopram for insomnia in elderly adults with ma…
-
CLINICAL_TRIALS trial_result · 2012-10-01Clinical Trial Update: Drug Use Investigation of Jzoloft.
A completed clinical trial for Jzoloft investigated its use in panic disorder and depression, with results posted in 2012.
-
FDA approval · 2012-10-01FDA Approved: FLUOXETINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original (ANDA) application for fluoxetine from Heritage Pharmaceuticals (d/b/a Avet), confirming a generic formulation of …
-
CLINICAL_TRIALS trial_result · 2012-09-28Clinical Trial Update: Screening and Interventions in an Acute Care Setting
University of Rochester-sponsored trial on screening and interventions in an acute care setting has completed and posted results.
-
FDA approval · 2012-09-27FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for fluoxetine from Aurobindo Pharma Limited, allowing the generic product to be marketed under the …
-
CLINICAL_TRIALS trial_result · 2012-09-27Clinical Trial Update: 6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive Disorder [Phase 2]
A Phase 2 study evaluating the safety and effectiveness of AZD2066 for major depressive disorder was terminated; results were posted in 2012…
-
CLINICAL_TRIALS research · 2012-09-27Clinical Trial Update: Cognitive Control Training as an Adjunct to Behavioral Activation Therapy in the Treatment of Depression [NA]
This clinical trial update discusses evaluating cognitive control training as an adjunct to behavioral activation therapy for depression. No…
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Effects of Repeated Attachment Security Priming on Depressed Mood: a Clinical Study [Phase 1]
A Phase 1 clinical trial from the University of Southampton investigates whether repeated attachment security priming can influence depresse…
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Study Assessing the Safety and Therapeutic Effect of Buprenorphine in MDD Patients [Phase 1]
Phase 1 clinical trial update assessing the safety and potential therapeutic effect of buprenorphine in patients with major depressive disor…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Mindfulness, Yoga, and Cardiovascular Disease [NA]
A completed clinical trial evaluating mindfulness and yoga interventions for cardiovascular disease and related stress, anxiety, and depress…
-
CLINICAL_TRIALS research · 2012-09-21Clinical Trial Update: Study of Mindfulness-Based Cognitive Therapy [NA]
A clinical trial update indicates that the mindfulness-based cognitive therapy study (NCT00943033) by Binghamton University on Major Depress…
-
CLINICAL_TRIALS trial_result · 2012-09-20Clinical Trial Update: Cognitive Bias Modification (CBM) and Internet Cognitive Behavioural Therapy (iCBT) for Depression- A Randomised Controlled Trial [NA]
A randomized controlled trial evaluating Cognitive Bias Modification (CBM) and Internet Cognitive Behavioural Therapy (iCBT) for depression …
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approval of a supplemental application for venlafaxine from BluePoint Laboratories (ANDA).
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for venlafaxine hydrochloride from Aurobindo Pharma Limited, resulting in approval of a generic venl…
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride submitted by Teva Pharmaceuticals USA, Inc., resulting in changes to t…
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for venlafaxine hydrochloride from Aurobindo Pharma Limited.
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride from Zydus Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors [Phase 3]
Phase 3 trial of omega-3 fatty acids for improving depression and reducing cardiovascular risk factors has completed and posted results.